Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Sanofi-aventis, Scripps to Partner on Personalized Medicines

DNA fragment (Wikimedia Commons)

(Wikimedia Commons)

Sanofi-aventis (U.S.) in Bridgewater, New Jersey and Scripps Genomic Medicine in San Diego, California announced today an alliance to advance research initiatives in individualized medicine.

Sanofi-aventis is a French pharmaceutical company, but with a U.S. subsidiary. Scripps Genomic Medicine is a division of Scripps Health, a private not-for-profit community health system in San Diego.

In the partnership, Sanofi-aventis’s R&D division will provide up to three grants per year to fund the work of Scripps Genomic Medicine researchers in the field of personalized medicine. In return, Sanofi-aventis will be granted non-exclusive rights to research tools developed through these grants, as well as preferred access to Scripps laboratory facilities for work conducted in support of sponsored research agreements and technologies or discoveries in this field.

Scripps and Sanofi-aventis also plan ongoing exchange and collaboration, beyond the field of personalized medicine, including a joint annual research symposium.

1 comment to Sanofi-aventis, Scripps to Partner on Personalized Medicines